PainChek General Discussion, page-54

PainChek cuts losses with first revenue from pain recognition app. The last sentence mentions The app is awaiting US regulatory approval from the Food and Drug Administration (FDA), and is confident it will pass by the end of 2018 for further global expansion of the technology.

https://unauthorised investment adv...s-losses-first-revenues-pain-recognition-app/

It was also mentioned to me that nViso will be listing later this year. nViso as we know power the AI behind PainChek and forgoed a 10% royalty to join the register where they hold just under 4% of PCK stock and are escrowed.

PainChek have an exclusive agreement to use their AI tech in the healthcare and pain recognition field and more collaboration opportunities may present themselves.

https://www.everblucapital.com/nviso-artificial-intelligence/